| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ATL(L) | 67 | 19.0% | 0.14 | 74 | 42.8% |
| PLP(L) | 138 | 39.2% | -inf | 0 | 0.0% |
| SCL(L) | 61 | 17.3% | -1.23 | 26 | 15.0% |
| CentralBrain-unspecified | 41 | 11.6% | -0.36 | 32 | 18.5% |
| SMP(L) | 24 | 6.8% | 0.66 | 38 | 22.0% |
| SLP(L) | 11 | 3.1% | -1.87 | 3 | 1.7% |
| LH(L) | 6 | 1.7% | -inf | 0 | 0.0% |
| CA(L) | 4 | 1.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ATL019 | % In | CV |
|---|---|---|---|---|---|
| LHPV4c1_b (L) | 4 | Glu | 44 | 14.3% | 0.4 |
| ATL021 (L) | 1 | Glu | 25 | 8.1% | 0.0 |
| LHPV4c1_c (L) | 3 | Glu | 19 | 6.2% | 0.5 |
| LHPV6o1 (L) | 1 | ACh | 18 | 5.8% | 0.0 |
| LHPV6f1 (L) | 4 | ACh | 16 | 5.2% | 0.6 |
| PS157 (L) | 1 | GABA | 14 | 4.5% | 0.0 |
| ATL027 (R) | 1 | ACh | 10 | 3.2% | 0.0 |
| LHPV5m1 (L) | 2 | ACh | 10 | 3.2% | 0.2 |
| M_smPN6t2 (R) | 1 | GABA | 9 | 2.9% | 0.0 |
| LHPV7a2 (L) | 2 | ACh | 9 | 2.9% | 0.8 |
| M_ilPNm90 (R) | 1 | ACh | 7 | 2.3% | 0.0 |
| IB116 (L) | 1 | GABA | 7 | 2.3% | 0.0 |
| ATL027 (L) | 1 | ACh | 6 | 1.9% | 0.0 |
| PLP116 (R) | 1 | Glu | 6 | 1.9% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 6 | 1.9% | 0.0 |
| ATL020 (L) | 2 | ACh | 6 | 1.9% | 0.3 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 5 | 1.6% | 0.0 |
| ATL021 (R) | 1 | Glu | 5 | 1.6% | 0.0 |
| PLP159 (L) | 1 | GABA | 4 | 1.3% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 4 | 1.3% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 4 | 1.3% | 0.0 |
| CB1976 (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| WEDPN2B_a (L) | 1 | GABA | 3 | 1.0% | 0.0 |
| LHPV5h4 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| ATL041 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| PLP071 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| CB1326 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CB3008 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| PLP116 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| KCab-p (L) | 1 | DA | 2 | 0.6% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| ATL002 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| PPL203 (L) | 1 | unc | 2 | 0.6% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| SLP334 (L) | 2 | Glu | 2 | 0.6% | 0.0 |
| ATL043 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| WED143_c (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| IB010 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| ATL018 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| ATL039 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP098 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2148 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV6h1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVP3 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| PLP124 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP028 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| SLP313 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LC36 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PPL204 (L) | 1 | DA | 1 | 0.3% | 0.0 |
| PS240 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3479 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| ATL032 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| LAL147_b (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| ATL038 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP189 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP457 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| IB048 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| ATL032 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| ATL029 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| ATL001 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| WED182 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| PLP247 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV5e3 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| ATL031 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| ATL014 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.3% | 0.0 |
| LHPV5e3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.3% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns ATL019 | % Out | CV |
|---|---|---|---|---|---|
| ATL041 (L) | 1 | ACh | 34 | 12.1% | 0.0 |
| ATL014 (L) | 1 | Glu | 28 | 10.0% | 0.0 |
| LHPD5f1 (L) | 1 | Glu | 11 | 3.9% | 0.0 |
| ATL020 (L) | 1 | ACh | 10 | 3.6% | 0.0 |
| ATL015 (L) | 1 | ACh | 10 | 3.6% | 0.0 |
| LAL148 (L) | 1 | Glu | 9 | 3.2% | 0.0 |
| PS157 (L) | 1 | GABA | 8 | 2.8% | 0.0 |
| ATL042 (L) | 1 | unc | 7 | 2.5% | 0.0 |
| LAL147_b (L) | 1 | Glu | 6 | 2.1% | 0.0 |
| IB010 (L) | 1 | GABA | 5 | 1.8% | 0.0 |
| FB2I_b (L) | 1 | Glu | 5 | 1.8% | 0.0 |
| ATL014 (R) | 1 | Glu | 5 | 1.8% | 0.0 |
| PLP247 (L) | 1 | Glu | 5 | 1.8% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 5 | 1.8% | 0.0 |
| PPL204 (R) | 1 | DA | 4 | 1.4% | 0.0 |
| SMP018 (L) | 1 | ACh | 4 | 1.4% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 4 | 1.4% | 0.0 |
| PPL204 (L) | 1 | DA | 4 | 1.4% | 0.0 |
| SMP490 (L) | 1 | ACh | 4 | 1.4% | 0.0 |
| LHPV5m1 (L) | 2 | ACh | 4 | 1.4% | 0.5 |
| ATL018 (L) | 2 | ACh | 4 | 1.4% | 0.5 |
| OA-VUMa6 (M) | 2 | OA | 4 | 1.4% | 0.5 |
| CL362 (L) | 1 | ACh | 3 | 1.1% | 0.0 |
| PLP064_a (L) | 1 | ACh | 3 | 1.1% | 0.0 |
| SLP365 (L) | 1 | Glu | 3 | 1.1% | 0.0 |
| FB2H_a (L) | 1 | Glu | 3 | 1.1% | 0.0 |
| SMP597 (L) | 1 | ACh | 3 | 1.1% | 0.0 |
| MBON35 (L) | 1 | ACh | 3 | 1.1% | 0.0 |
| ATL018 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| ATL043 (L) | 1 | unc | 2 | 0.7% | 0.0 |
| ATL039 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| SMP016_a (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| SMP441 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| LAL150 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| CL136 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| LAL147_a (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| SIP081 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| ATL038 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| ATL003 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| LHPD2d1 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| SMP183 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| ExR3 (L) | 1 | 5-HT | 2 | 0.7% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| CL098 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| SMP409 (L) | 2 | ACh | 2 | 0.7% | 0.0 |
| ATL036 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| PLP258 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP048 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV5l1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP142 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| ATL025 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP098 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP542 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| IB049 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP217 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV1c1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| AVLP475_b (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP134 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP017 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP410 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4155 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV5h2_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP243 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL013 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| WED143_c (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL009 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| PLP124 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV4c1_b (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| ATL012 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP156 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL045 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP256 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP064_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL027 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL026 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV7a2 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL012 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP457 (R) | 1 | unc | 1 | 0.4% | 0.0 |
| ATL027 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| IB048 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SAD034 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL001 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| ATL029 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SAD034 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| ATL030 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.4% | 0.0 |
| ATL002 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| ATL021 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV5e3 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.4% | 0.0 |
